RENAL FUNCTION IN ADOLESCENTS WITH OBESITY

THE AIM. Determining the effect of obesity on renal function in children. PATIENTS AND METHODS. The study included 35 adolescents (30 boys and 5 girls, mean age 14.6±2.2 years) with overweight and differing degrees of obesity. In addition to clinical examination determined the presence and severity of risk factors for kidney disease in obesity, especially insulin resistance, lipid metabolism with the definition of atherogenic index (AI). To assess kidney function determined microalbuminuria (MAU) and glomerular filtration rate. RESULTS. Renal function in adolescents with obesity which manifests with increasing the excretion of albumin and decreasing the glomerular filtration rate (GFR) caused by lipid metabolism disorders: increase of lowdensity lipoprotein (LDL) level and decrease of high-density lipoprotein (HDL) level, which reflected on the atherogenic atherogenic index. The correlation between the level of MAU and GFR and atherogenic index (r= 0,42;p<0,05; r = -0,37;p<0.05) was shown, whereas between blood pressure and MAU, as well as between the degree of IR and impaired renal function in adolescents with obesity was absent. We have not found a relationship between blood pressure and MAU, as well as between the degree of IR and renal disorder in adolescents with obesity. Severity of IR depends on the level of HDL (r= -0,52; p<0,05). Disorder of BP biorhythm as insufficient diastolic night fall significantly affected on the renal function in the form of MAU (r = -0,37; p <0,05). It was found that the degree of overweight is not in direct correlation with the degree of lipid metabolism disorder (r = 0,2; p> 0,05). CONCLUSION. In adolescents with overweight and obesity renal function is inversely proportional correlated with severity of lipid metabolism disorder, intensity of which is not dependent on the degree of overweight.

1. Lobstein T, Baur L, Uauy R. IASO International Obesit TaskForce. Obesity in children and young people: a crisis in public health. Obes Rev 2004; 5 Suppl 1: 4-104

2. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and metaanalysis. Kidney Int 2008; 73: 19-33

3. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 550-562

4. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-244

5. Майров АЮ, Урбанова КА, Галстян ГР. Современные представления о методах оценки инсулирезистентности. Вестн репродуктивного здоровья 2008; (3-4): 8-12. [Majorova AU, Ubanovich KA, Galstyan GR. Sovremennye predstavlenija o metodah ocenki insulinrezistentnosti. Vestnik reproduktivnogo zdorovja 2008; (3-4): 8-12.]

6. McCrindle BW, Urbina EM, Dennison BA et al. Drug therapy of high risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967

7. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412—419.

8. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care 2004; 27: 6: 1487—1495

9. Alberti KGMM, Zimmet PZ, Shaw JE. The metabolic syndrome in children and adolescents. Lancet 2007; 369: 2059-2061

10. Дедов ИИ, Мельниченко ГА, Романцова ТИ. Патогенетические аспекты ожирения. Ожирение и метаболизм 2004; (1): 3–9 [Dedov II, Mel’nichenko GA, Romancova TI. Patogeneticheskie aspekty ozhirenija. Ozhirenie i metabolizm 2004; (1): 3–9]

11. Кучер АГ, Смирнов АВ, Каюков ИГ и др. Лептин – новый гормон жировой ткани: значение в развитии ожирения, патологии сердечнососудистой системы и почек. Нефрология 2005; 9(1): 9-19 [Kucher AG, Smirnov AV, Kaiukov IG i dr. Leptin – novy`i` gormon zhirovoi` tkani: znachenie v razvitii ozhireniia, patologii serdechno sosudistoi` sistemy` i pochek. Nefrologiia 2005; 9(1): 9-19]

12. Кутырина И, Краснова Е, Федорова Е, Фомин В. Поражение почек при ожирении: клинические, патогенетические и терапевтические аспекты. Врач 2005; (6): 6-9 [Kutyrina I, Krasnova E, Fedorova E, Fomin V. Porazhenie pochek pri ozhirenii: klinicheskie, patogeneticheskie i terapevticheskie aspekty. Vrach 2005; (6): 6-9]

13. Вялкова АА, Лебедева ЕН, Красиков СИ и др. Клиникопатогенетические аспекты повреждения почек при ожирении (обзор литературы). Нефрология 2014; (3): 24-33 [Vyalkova AA, Lebedeva EN, Krasikov CI i dr. Kliniko-patogeneticheskie aspekty povrezdenia pochek pri ogirenii. Nephrologia 2014; (3): 24-33]